Literature DB >> 22403332

Capillary leakage in travelers with dengue infection: implications for pathogenesis.

Eyal Meltzer1, Zahava Heyman, Hanna Bin, Eli Schwartz.   

Abstract

Dengue hemorrhagic fever is characterized by the presence of a capillary leak syndrome. Its pathogenesis is presumed to differ from that of classical dengue fever (DF) and to be associated with secondary dengue infection. Returning travelers given a diagnosis of DF were evaluated for capillary leakage with abdominal sonography. Data were compared between travelers with primary/secondary infection defined by epidemiologic and serologic parameters. A total of 12 (34.3%) of 35 patients had sonographic signs of capillary leakage. Most (85%) patients with capillary leakage had classical DF. Capillary leak was diagnosed in 32% of primary dengue cases and in 40% of secondary dengue cases (P = 0.69). The two patients given a diagnosis of dengue hemorrhagic fever had primary infections. The high prevalence of capillary leakage among travelers, most of them with primary exposure to dengue, calls into question the importance of secondary infection in causing capillary leakage in dengue infection.

Entities:  

Mesh:

Year:  2012        PMID: 22403332      PMCID: PMC3284377          DOI: 10.4269/ajtmh.2012.10-0670

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  17 in total

1.  Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers.

Authors:  E Schwartz; F Mileguir; Z Grossman; E Mendelson
Journal:  J Clin Virol       Date:  2000-12       Impact factor: 3.168

Review 2.  Understanding dengue pathogenesis: implications for vaccine design.

Authors:  John R Stephenson
Journal:  Bull World Health Organ       Date:  2005-04-25       Impact factor: 9.408

3.  Role of ultrasound in dengue fever.

Authors:  P M Venkata Sai; B Dev; R Krishnan
Journal:  Br J Radiol       Date:  2005-05       Impact factor: 3.039

4.  A reappraisal of the criteria to diagnose plasma leakage in dengue hemorrhagic fever.

Authors:  S Balasubramanian; Lalitha Janakiraman; S Shiv Kumar; S Muralinath; So Shivbalan
Journal:  Indian Pediatr       Date:  2006-04       Impact factor: 1.411

Review 5.  Severe dengue: the need for new case definitions.

Authors:  José G Rigau-Pérez
Journal:  Lancet Infect Dis       Date:  2006-05       Impact factor: 25.071

6.  Clinical features of 62 imported cases of dengue fever in Japan.

Authors:  Ichiro Itoda; Gohta Masuda; Akihiko Suganuma; Akifumi Imamura; Atsushi Ajisawa; Ken-Ichiro Yamada; Sadao Yabe; Tomohiko Takasaki; Ichiro Kurane; Kyoichi Totsuka; Masayoshi Negishi
Journal:  Am J Trop Med Hyg       Date:  2006-09       Impact factor: 2.345

7.  Fatal dengue virus infection in a Finnish traveler.

Authors:  Eili Huhtamo; Sakari Vuorinen; Nathalie Y Uzcátegui; Olli Vapalahti; Hannu Haapasalo; Jukka Lumio
Journal:  J Clin Virol       Date:  2006-10-11       Impact factor: 3.168

8.  Dengue fever among Swedish tourists.

Authors:  B Wittesjö; R Eitrem; B Niklasson
Journal:  Scand J Infect Dis       Date:  1993

Review 9.  Laboratory diagnosis of dengue virus infection: current and future perspectives in clinical diagnosis and public health.

Authors:  Chuan-Liang Kao; Chwan-Chuen King; Day-Yu Chao; Hui-Lin Wu; Gwong-Jen J Chang
Journal:  J Microbiol Immunol Infect       Date:  2005-02       Impact factor: 4.399

Review 10.  Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes.

Authors:  Scott B Halstead; Suresh Mahalingam; Mary A Marovich; Sukathida Ubol; David M Mosser
Journal:  Lancet Infect Dis       Date:  2010-10       Impact factor: 25.071

View more
  9 in total

Review 1.  Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis.

Authors:  Ashley L St John; Soman N Abraham; Duane J Gubler
Journal:  Nat Rev Microbiol       Date:  2013-05-08       Impact factor: 60.633

2.  Zika Virus in Israeli Travelers: Emergence of Asia as a Major Source of Infection.

Authors:  Eyal Meltzer; Yaniv Lustig; Eli Schwartz
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

Review 3.  Cardiovascular manifestations of the emerging dengue pandemic.

Authors:  Sophie Yacoub; Heiman Wertheim; Cameron P Simmons; Gavin Screaton; Bridget Wills
Journal:  Nat Rev Cardiol       Date:  2014-04-08       Impact factor: 32.419

Review 4.  Tourniquet Test for Dengue Diagnosis: Systematic Review and Meta-analysis of Diagnostic Test Accuracy.

Authors:  Antonio Jose Grande; Hamish Reid; Emma Thomas; Charlie Foster; Thomas C Darton
Journal:  PLoS Negl Trop Dis       Date:  2016-08-03

Review 5.  [Dengue fever : Symptoms, epidemiology, entomology, pathogen diagnosis and prevention].

Authors:  D Wiemer; H Frickmann; A Krüger
Journal:  Hautarzt       Date:  2017-12       Impact factor: 0.751

6.  The predictive diagnostic value of serial daily bedside ultrasonography for severe dengue in Indonesian adults.

Authors:  Meta Michels; Uun Sumardi; Quirijn de Mast; Hadi Jusuf; Mita Puspita; Intan Mauli Warma Dewi; Sylvia Sinarta; Bachti Alisjahbana; André J A M van der Ven
Journal:  PLoS Negl Trop Dis       Date:  2013-06-13

Review 7.  Can non-human primates serve as models for investigating dengue disease pathogenesis?

Authors:  Kristina B Clark; Nattawat Onlamoon; Hui-Mien Hsiao; Guey C Perng; Francois Villinger
Journal:  Front Microbiol       Date:  2013-10-11       Impact factor: 5.640

Review 8.  Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome.

Authors:  Jih-Jin Tsai; Kulkanya Chokephaibulkit; Po-Chih Chen; Li-Teh Liu; Hui-Mien Hsiao; Yu-Chih Lo; Guey Chuen Perng
Journal:  J Biomed Sci       Date:  2013-12-05       Impact factor: 8.410

9.  Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation.

Authors:  Adwoa D Bentsi-Enchill; Julia Schmitz; Robert Edelman; Anna Durbin; John T Roehrig; Peter G Smith; Joachim Hombach; Jeremy Farrar
Journal:  Vaccine       Date:  2013-04-06       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.